BioSpace - Financial Content

CRUCELL SP.ADR Add to My Watchlist

(NSDQ: CRXL)

Detailed Quote

Last Price	21.62 (11.20.09 5:20 PM EST)
Change (%)	+0.17 (+0.79%)
Volume	77,929
Open	21.40
Previous Close	21.45
Day High	21.71
Day Low	21.36
Bid	21.59 x 400
Ask	21.62 x 100

Average Volume	343,333
Shares Outstanding	66.60M
Market Cap	1.4B
Year High	25.53
Year Low	11.29
Earnings Per Share	N/A
P/E Ratio	N/A
Dividend	N/A
Yield	N/A

Intraday

3 Month

6 Month

1 Year

Symbol	Last	Change (%)
MYGN	23.60	+0.14 (+0.60%)
CRL	32.44	+0.00 (+0.00)
MEDX	16.02	+0.00 (+0.00)
GPRO	41.71	-0.29 (-0.69%)
OSIP	32.79	-0.07 (-0.21%)
AMLN	12.44	-0.33 (-2.58%)
INRLF	37.01	+0.00 (+0.00)

Mon, Nov 16, 2009
	2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer - PR Newswire
	Crucell launches global brand to reflect and reinforce its leading position in healthcare innovation - Marketwire
Thu, Nov 05, 2009
	TapImmune Signs License Agreement With Crucell N.V. - GlobeNewswire
	Stocks on the Move: TPIV, INO, MBCI, CRXL NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Smallcap-Investors.com. - Marketwire
Tue, Nov 03, 2009
	Calmune and Crucell Enter Exclusive Research Collaboration Calmune to Use Proprietary Technology Platform to Generate Potent Human Monoclonal Antibodies Against Infectious Diseases - Marketwire
More Press Releases

Mon, Nov 16, 2009
	Crucell NV management to meet with Caris See the rest of the story here. Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself. - theflyonthewall.com
Thu, Nov 05, 2009
	TapImmune (TPIV) In License Agreement with Crucell (CRXL) Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5078405 for the full story. - StreetInsider
	UBS Upgrades Crucell NV (CRXL) to Buy Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5078303 for the full story. - StreetInsider
	Crucell NV upgraded to Buy from Neutral at UBS See the rest of the story here. Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself. - theflyonthewall.com
Tue, Nov 03, 2009
	Johnson & Johnson to cut up to 8,200 jobs Johnson & Johnson said Tuesday that it plans to cut up to 7% of its roughly 117,000-person workforce, or about 8,200 jobs, in an effort to save between $1.4 billion and $1.7 billion a year in costs. - MarketWatch
More News

Fri, Oct 16, 2009
	(ABT) Two Pharmas Are Better Than One – Here Are the Ones to Buy in This Merger-Mad Industry Tony Daltorio, Investment U Research Pharmaceutical companies have launched themselves into the fall season with a vengeance, gobbling up acquisitions like dots on a Pac-Man board. The most notable recent buyout was a deal that sees Abbott Laboratories (NYSE: ABT) expand both its product range and its presence in notable emerging nations with [...] (ABT) Two Pharmas Are Better Than One – Here Are the Ones to Buy in This Merger-Mad Industry - Stock Blog Hub
Mon, Sep 28, 2009
	Flurry Of Mergers And Acquisitions Drives Stock Market Rally A flurry of mergers-and-acquisition deals in the pharmaceutical and technology industries Monday sparked a sharp market rally, snapping a three-day losing streak and giving stocks to their biggest gains in five weeks. The pickup in merger activity bolstered arguments that mergers and acquisitions (M&A) are rebounding from the biggest slump in six ... - Daily Markets
	Post Market Summary: Wall Street Rallies On Merger Deals, American Express (NYSE: AXP) Soars US stocks rallied on Monday as a rise in merger and acquisition activity lifted investor sentiment.[More...] - home: iStockAnalyst....
	Stock Market Briefs: Xerox, Johnson & Johnson, Kraft, Cadbury, Toyota Xerox (XRX) is buying Affiliated Computer Services (ACS) for $6.4 billion or $63.11 per share, equaling $18.60 in cash plus 4.935 Xerox shares for each ACS share owned. Johnson & Johnson (JNJ) said they have purchased 18.1% of Crucell (CRXL) for $440 million, a 30% premium to Friday’s close. Kraft Foods (KFT) is likely ... - Daily Markets
	ETF Preview: ETFs Mostly Higher as M&A News Bolsters Stocks. Xerox (XRX) Buys Affiliated Computer (ACS) Major market ETFs, including the SPY, DIA, UYG and others, are mostly firmer, getting a boost from the broader market on mergers and acquisitions news. Stocks are so far setting up for early gains, after Xerox (XRX) says it will buy Affiliated Computer Services (ACS) in a $6.4 billion deal and a handful of healthcare companies made some smaller purchases.[More...] - home: iStockAnalyst....
More Blogs

11/03/09		Q3 2009 Earnings Archive for CRXL
09/28/09		Special Conference Johnson and Johnson and Crucell Announce Strategic Collaboration to Develop Innovative Products, Including Therapies for Influenza Prevention and Treatment Archive for CRXL
09/22/09		Special Conference 2009 Global Life Sciences Conference Archive for CRXL
08/11/09		Q2 2009 Earnings Archive for CRXL
06/02/09		Special Conference Global Specialty Pharmaceuticals Conference Archive for CRXL

Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Real Time Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs